Clinical trialNCT07519395RecruitingPhase 2Interventional

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

SponsorGlaxoSmithKlineEnrollment420Irritable Bowel Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is designed to evaluate the efficacy and safety of camlipixant in adults with IBS-D and IBS-M. The study has two parts. After the first part, some participants will be randomly chosen again to either get a higher dose or stop the drug.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

GSK Clinical Trials
GlaxoSmithKline
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Gsk Investigational Site
Anniston, Alabama, United States
Pankaj Kashyap
Recruiting
Gsk Investigational Site
Guntersville, Alabama, United States
William A Nixon
Recruiting
Gsk Investigational Site
Mobile, Alabama, United States
Jonathan Siegel
Recruiting
Gsk Investigational Site
Saraland, Alabama, United States
Howard Rubenstein
Recruiting
Gsk Investigational Site
Scottsdale, Arizona, United States
Todd Dreitzler
Recruiting
Gsk Investigational Site
Tempe, Arizona, United States
Joseph Davis
Recruiting
Gsk Investigational Site
Anaheim, California, United States
Amit Bhanvadia
Recruiting
Gsk Investigational Site
Chula Vista, California, United States
Erick Alayo
Recruiting
Gsk Investigational Site
Coronado, California, United States
Tarek Hassanein
Recruiting
Gsk Investigational Site
Garden Grove, California, United States
Michael Kurtz
Recruiting
Gsk Investigational Site
Lancaster, California, United States
Kumaravel Perumalsamy
Recruiting
Gsk Investigational Site
Lancaster, California, United States
Jatinder Pruthi
Recruiting
Gsk Investigational Site
Los Angeles, California, United States
Myanh Pardee
Recruiting
Gsk Investigational Site
Murrieta, California, United States
John Hong
Recruiting
Gsk Investigational Site
Pasadena, California, United States
John De Beixedon
Recruiting
Gsk Investigational Site
San Diego, California, United States
Sajiv Chandradas
Recruiting
Gsk Investigational Site
San Diego, California, United States
Fazeel Shah
Recruiting
Gsk Investigational Site
Sherman Oaks, California, United States
Shahram Jacobs
Recruiting
Gsk Investigational Site
West Hills, California, United States
Hessam Aazami
Recruiting
Gsk Investigational Site
Aurora, Colorado, United States
Timothy Colander
Recruiting
Gsk Investigational Site
Colorado Springs, Colorado, United States
Bhaktasharan Patel
Recruiting
Gsk Investigational Site
Lone Tree, Colorado, United States
Carlene Chun
Recruiting
Gsk Investigational Site
Brandon, Florida, United States
GERMAN ALVAREZ
Recruiting
Gsk Investigational Site
Clearwater, Florida, United States
Michael Weiss
Recruiting
Gsk Investigational Site
Coral Gables, Florida, United States
Jorge Beato
Recruiting
Gsk Investigational Site
Doral, Florida, United States
Osvaldo Carmona
Recruiting
Gsk Investigational Site
Hialeah, Florida, United States
Isaac Bassan
Recruiting
Gsk Investigational Site
Homestead, Florida, United States
Roberto Fernandez
Recruiting
Gsk Investigational Site
Jacksonville, Florida, United States
Kristian Sanchack
Recruiting
Gsk Investigational Site
Kissimmee, Florida, United States
Basher Atiquzzaman
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Onix Garib Alpizar
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Alexander Veloso
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Carlos Ramos
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Maurin Jimenez
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Mirel Sanchez
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Carlos Selema
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Maria Nualart
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Felix Penate
Recruiting
Gsk Investigational Site
Miami, Florida, United States
Celia Padron
Recruiting
Gsk Investigational Site
Miami Beach, Florida, United States
Ricardo Mauro Perez Rivera
Recruiting

70 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CamlipixantPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Apr 2026
Primary completion: 9 Mar 2027
Completion: 13 Jul 2027
Last update posted: 25 Jun 2026
Registered enrollment: 420
Registry id: NCT07519395

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.